Bioanalysis
My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference
My fellow Altascientists and I recently attended the 2024 annual Boston Society Gen
Development of an Assay for Atropine in Rabbit Plasma by LC/MS/MS and the Impact of Atropine Esterase
Maximize Assay Sensitivity and Minimize Costs
Strategies to Improve Assay Sensitivity to Quantify Therapeutic Oligonucleotides
Are you looking for assays with enhanced sensitivity and minimal sample clean-up in small volumes?
We can help.
Our strategies enhance analytical sensitivity, reduce assay costs, and streamline workflows, optimizing the efficiency and cost-effectiveness of your research and development processes.
Discover this in this real-world example
You may also be interested in the below:
Webinar:
Webpages:
Discover Our Truly Integrated Clinical and Bioanalytical Solution
The True Meaning of Moving in Unison
Join our VP of Global Clinical Operations, Ingrid Holmes, and our VP of Laboratory Sciences, Lynne Le Sauteur, as they share the secrets to the success of our integrated clinical and bioanalytical solution. You won't want to miss this!
Watch the full interview or keep scrolling to jump to a specific section.
- Proprietary Scheduling System:
In this video, discover our game-changing, proprietary scheduling system, which is essential for hitting key client deliverables and managing internal milestones across departments and services with precision.
Explore more about our innovative scheduling system here. - Advantages of Being a Mid-Sized CRO:
Flexibility and customized service are at the core of our operations. Our mid-sized stature allows for seamless communication between departments while offering comprehensive services.
Discover the benefits of partnering with a flexible, mid-sized CRO here. - Successful Project Case Study:
In this interview, we highlight a real-world example of a challenging project where seamless communication and coordination, and the proximity of our lab and clinic were pivotal to exceeding client expectations and delivering outstanding results.
See how we tackle complex projects successfully here.
You may also be interested in the following webpages:
Sensitive Quantitation of Antisense Oligonucleotides Using Capitainer® qDBS Microsampling Device Coupled with Hybridization LC-MS/MS
Inside The Altascientist: Unpacking the Bioanalytical and Regulatory Considerations for Antisense Oligonucleotide (ASO) Studies
Antisense oligonucleotides—or ASOs—are short, synthetic, single-stranded oligonucleotides extensively used for altering RNA expression to reduce, restore, or modify protein expression via several distinct mechanisms.
Strategies to Improve Assay Sensitivity to Quantify Therapeutic Oligonucleotides
Singlicate Analysis in Ligand Binding Assays From Discovery to Regulated Clinical Studies: Implementation Strategies and Benefits
FREE ON-DEMAND WEBINAR—Key Considerations for Nonclinical AAV Gene Therapy
From Screening to PCR Analysis
In this webinar on AAV gene therapy, we explore pre-existing immunity challenges, vector targets, biodistribution, and the role of PCR analysis in assessing therapy efficacy and safety.
Also included are case studies that highlight the delicate balance between innovation and regulatory compliance.
You may also be interested in the following:
The Altascientist
• qPCR and ddPCR—Leading-Edge Analysis for Gene Therapy Programs
• Nonclinical Studies in Cell and Gene Therapy
Webpages
• Bioanalytical Services
• Preclinical Services
Inside The Altascientist: The Benefits of PCR for Your Gene Therapy Programs
The gene therapy landscape continues to accelerate in preclinical and clinical research, with programs constantly in development for targeted, personalized medicines. The goal is to safely incorporate genetic alterations to restore and repair the proteins of missing and/or faulty genes.